A pilot study to investigate the efficacy of dexamphetamine to treat obesity using dosage titratio

Phase 2

Recruiting

• Conditions: Obesity; Diet and Nutrition - Obesity

• Registration Number: ACTRN12612000831886
• Lead Sponsor: epean Blue Mountains Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

BMI > 30

Exclusion Criteria

Unstable heart disease
Uncontrolled hypertension
History of addiction to illicit drugs
uncontrolled epilepsy
weight change of +/- 3kg the past 3 months
breastfeeding, pregnant or planning pregnancy
current depression or other psychiatric illness
current or recent treatment (past 12 months) with psychotropic medication, systemic glucocorticoids or medication for weight loss (eg orlistat)
family history of sudden death from cardiac causes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight loss from baseline (difference between weight in kg at baseline and weight in kg at 3, 6 and 12 months)[3, 6 and 12 months]

Secondary Outcome Measures

Name	Time	Method
Maintenance of weight loss, as determined by change in weight (kg) over the 6 months following cessation of treatment[12 months]